Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce E Johnson

Showing results (131-140 of 284) with videos related to

Pageof 29
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|August 26, 2010
Virginia Tech Carilion School of Medicine and Research InstituteRichard C Vari, Terri F Workman, Daniel P Harrington, et al.
AJR. American Journal of Roentgenology|August 24, 2010
New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapyMizuki Nishino, David M Jackman, Hiroto Hatabu, et al.
American Journal of Clinical Oncology|June 1, 2002
Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancerO S Breathnach, V Kasturi, F Kaye, et al.
Cancer|June 11, 2008
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesotheliomaDavid M Jackman, Hedy L Kindler, Beow Y Yeap, et al.
Cancer|June 25, 2009
Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgeryHale B Caglar, Elizabeth H Baldini, Megan Othus, et al.
Cancer|August 23, 2008
Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinomaAli G Saad, Beow Y Yeap, Frederik B J M Thunnissen, et al.
CA: a Cancer Journal for Clinicians|March 1, 2023
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guideAdam H Fox, Mizuki Nishino, Raymond U Osarogiagbon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
The introduction of systematic genomic testing for patients with non-small-cell lung cancerStephanie Cardarella, Taylor M Ortiz, Victoria A Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2012
The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutationsStephanie Heon, Beow Y Yeap, Neal I Lindeman, et al.
Radiology|May 7, 2008
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening studyPamela M McMahon, Chung Yin Kong, Bruce E Johnson, et al.
Pageof 29

Showing results (131-140 of 284) with videos related to

Sort By:
Pageof 29
Academic Medicine : Journal of the Association of American Medical Colleges|August 26, 2010
Virginia Tech Carilion School of Medicine and Research InstituteRichard C Vari, Terri F Workman, Daniel P Harrington, et al.
AJR. American Journal of Roentgenology|August 24, 2010
New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapyMizuki Nishino, David M Jackman, Hiroto Hatabu, et al.
American Journal of Clinical Oncology|June 1, 2002
Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancerO S Breathnach, V Kasturi, F Kaye, et al.
Cancer|June 11, 2008
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesotheliomaDavid M Jackman, Hedy L Kindler, Beow Y Yeap, et al.
Cancer|June 25, 2009
Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgeryHale B Caglar, Elizabeth H Baldini, Megan Othus, et al.
Cancer|August 23, 2008
Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinomaAli G Saad, Beow Y Yeap, Frederik B J M Thunnissen, et al.
CA: a Cancer Journal for Clinicians|March 1, 2023
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guideAdam H Fox, Mizuki Nishino, Raymond U Osarogiagbon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
The introduction of systematic genomic testing for patients with non-small-cell lung cancerStephanie Cardarella, Taylor M Ortiz, Victoria A Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2012
The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutationsStephanie Heon, Beow Y Yeap, Neal I Lindeman, et al.
Radiology|May 7, 2008
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening studyPamela M McMahon, Chung Yin Kong, Bruce E Johnson, et al.
Pageof 29